Efficient synthesis of neocryptotanshinone: Evaluation of acute toxicity and therapeutic efficacy against doxorubicin-induced cardiotoxicity

New insights into therapeutic strategies, drugs, and targets for advancing cancer therapy-related cardiovascular toxicity

10.1016/j.scib.2025.02.004 · doi-reference

Anthracycline-induced cardiotoxicity: emerging mechanisms and therapies

10.1016/j.medp.2025.100074 · doi-reference

Concordance of the toxicity of pharmaceuticals in humans and in animals

10.1006/rtph.2000.1399 · doi-reference

Quinone derivatives by chemical transformations of 16-hydroxycarnosol from Salvia species

10.1248/cpb.53.1524 · doi-reference

The antidiabetic activities of neocryptotanshinone: screened by molecular docking and related to the modulation of PTP1B

10.3390/nu14153031 · doi-reference

Effectiveness and safety of Danshen injections in the treatment of cardiac failure: a network meta-analysis

10.3389/fphar.2024.1319551 · doi-reference

Efficacy and safety of Danshen class injections in the treatment of coronary heart disease: a network meta-analysis

10.3389/fphar.2024.1487119 · doi-reference

Asymmetric total synthesis of (+)-isocryptotanshinone and formal synthesis of (−)-cryptotanshinone

10.1016/j.tet.2019.05.069 · doi-reference

Two new fatty diterpenoids from Salvia miltiorrhiza

10.1021/np000345v · doi-reference

Diterpenoids from Salvia miltiorrhiza

10.1016/s0031-9422(99)00433-1 · doi-reference

Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha

10.1016/j.biopha.2023.114868 · doi-reference

A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza

10.1124/jpet.105.100701 · doi-reference

Pharmacokinetics, tissue distribution, and excretion study of neocryptotanshinone in rats using liquid chromatography-tandem mass spectrometry

10.1002/sscp.202300095 · doi-reference

Isolation and bioactivity of new tanshinones

10.1021/np50050a004 · doi-reference

Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating the Nrf2 signaling pathway

10.1016/j.phymed.2022.154439 · doi-reference

TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of dihydrotanshinone I in doxorubicin-induced cardiotoxicity

10.1186/s13046-020-01595-x · doi-reference

Salviae Miltiorrhizae Radix et Rhizoma protects against doxorubicin-induced cardiotoxicity: a systematic review

10.1016/j.phymed.2025.157244 · doi-reference

Tanshinone IIA protects against heart failure post-myocardial infarction via the AMPK/mTOR-dependent autophagy pathway

10.1016/j.biopha.2019.108599 · doi-reference

Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases

10.1016/j.biopha.2020.110599 · doi-reference

Tanshinones, critical pharmacological components in Salvia miltiorrhiza

10.3389/fphar.2019.00202 · doi-reference

Research progress on the pharmacological properties of active ingredients from Salvia miltiorrhiza: a review

10.1016/j.phymed.2025.157272 · doi-reference

Danqi pill protects against heart failure post-acute myocardial infarction via the HIF-1α/PGC-1α-mediated glucose metabolism pathway

10.3389/fphar.2020.00458 · doi-reference

The roles of the mitophagy inducer Danqi pill in heart failure: a new therapeutic target to preserve energy metabolism

10.1016/j.phymed.2022.154009 · doi-reference

Salvia miltiorrhiza Bunge (Danshen): a golden herbal medicine in cardiovascular therapeutics

10.1038/aps.2017.193 · doi-reference

Ethnomedicine, phytochemistry, pharmacology, pharmacokinetics, and clinical application of Salvia miltiorrhiza Bunge (Lamiaceae): a comprehensive review

10.1016/j.jep.2025.120032 · doi-reference